Class-action lawsuit alleges company misled the health care industry
A California doctor is suing Kleenex maker Kimberly-Clark for more than $500 million for allegedly misleading health care professionals into believing that one of its surgical gowns provided a superior amount of protection against exposure to Ebola — despite the fact that many of the gowns experienced “catastrophic failures” during product safety tests.
The class-action lawsuit claims that Kimberly-Clark knew as early as 2013 that its MICROCOOL Breathable High Performance Surgical Gowns were unsafe and thus put doctors and patients at “serious risk” of exposure to Ebola, among other diseases transmissible through bodily fluids. Despite this knowledge, the lawsuit states that the company continued to market the gowns to the health care industry.
Kimberly-Clark started selling the gowns in 2011 and controls more than 50 percent of the surgical gown market, according to the lawsuit. The company has sold millions of the gowns, lead attorney Michael Avenatti told Reuters.
“Kimberly-Clark needs to immediately recall these gowns and come clean with the FDA, CDC, healthcare professionals and the general public,” Avenatti said in a statement, according to Reuters. “The risks associated with continued concealment of the truth are far too great.”
The company told TINA.org that it does not comment on pending litigation.
Click here for more of our coverage on the marketing of Ebola-related products.
Verizon remains committed to its program of inserting a tracking number into its customers’ cellphone transmissions
AT&T says it has stopped its controversial practice of adding a hidden, undeletable tracking number to its mobile customers' Internet activity.
"It has been phased off our network," said Emily J. Edmonds, an AT&T spokeswoman.
The move comes after AT&T and Verizon received a slew of critical news coverage for inserting tracking numbers into their subscribers' Internet activity, even after users opted out. Last month, ProPublica reported that Twitter's mobile advertising unit was enabling its clients to use the Verizon identifier. The tracking numbers can be used by sites to build a dossier about a person's behavior on mobile devices – including which apps they use, what sites they visit and for how long.
The controversial type of tracking is used to monitor users' behavior on their mobile devices where traditional tracking cookies are not as effective. The way it works is that a telecommunications carrier inserts a uniquely identifying number into all the Web traffic that transmits from a users' phone.
AT&T said it used the tracking numbers as part of a test, which it has now completed.
Edmonds said AT&T may still launch a program to sell data collected by its tracking number, but that if and when it does, "customers will be able to opt out of the ad program and not have the numeric code inserted on their device."
A Verizon spokeswoman says its tracking program is still continuing, but added "as with any program, we're constantly evaluating."
Verizon offers its customers an opportunity to opt out of the program. But opting out doesn't remove the tracking ID.
The anticipation of disaster is often worse than the disaster itself
Ellen Langer is probably the longest serving psychologist at Harvard, at 67 years. No one, to date, has done as much research as she has on the connection between the human mind and disease.
Her research has brought to light the vital role that mind plays in causing as well as curing disease. She is the one who gave respectability to the placebo effect—the good that a positive mindset can do for the body. She showed that the fear of disease and negative prognoses, especially in cancer and heart disease, are among the most important factors that interfere with the body’s healing capacity, also termed the ‘Nocebo’ effect.